MedPal AI Launches New Health — £1.3m Push Into GLP-1
Episode 2404 · May 21, 07:50 AM
Share
Subscribe
MedPal AI (AIM: MPAL) launches New Health, a standalone GLP-1 sub-brand backed by £1.3 million of marketing, ahead of expected UK approval of Novo Nordisk’s oral Wegovy. CEO Jason Drummond on the strategy, the market, and the unit economics behind it.